Scholarlink

In hemodialysis (HD) population, there is ambiguity regarding the relationship between hypertension (HTN) and adverse outcomes. In the patients undergoing dialysis, cardiovascular disease is primarily triggered by HTN. The first approach would be to accurately determine blood pressure (BP) of patients undergoing HD. The accurate diagnosis of HTN is made through assessment of home BP, ambulatory BP, pre-dialytic BP, as well as intradialytic BP. Limiting salt intake in food and modifying dialysate sodium delivery are the first stages in managing HTN in end-stage renal disease (ESRD) patients. Although it is uncertain if controlling HTN will lead to improved results, the availability of data indicates the need to manage HTN in HD patients. The key component of therapy thus involves volume status optimization, with an additional antihypertensive medicine used as suitable. The presence of HTN is a leading cause of the reduced quality of life (QoL) of HD patients. To define BP targets and monitoring methods, as well as to develop therapeutic options for more effective management of HTN in this high-risk group of HD patients, high-quality prospective studies are essential. Published data from Pakistan is insufficient when it comes to the management of uncontrolled HTN in HD patients and the factors that contribute to it.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Hypertensive Hemodialysis Patient: Features and Quality of Life Domains—Pakistan Perspectives

  • 工具书词条

  • 发表日期：

    2025年

查看全文
  • Shahid Shah,
  • Ghulam Abbas,
  • Anees Ur Rehamn,
  • Muhammad Irfan,
  • Akhtar Rasul,
  • Muhammad Hanif,
  • Matti Ullah,
  • Abid Mahmood,
  • Laraib Akram,
  • Rafia Noor

摘要

In hemodialysis (HD) population, there is ambiguity regarding the relationship between hypertension (HTN) and adverse outcomes. In the patients undergoing dialysis, cardiovascular disease is primarily triggered by HTN. The first approach would be to accurately determine blood pressure (BP) of patients undergoing HD. The accurate diagnosis of HTN is made through assessment of home BP, ambulatory BP, pre-dialytic BP, as well as intradialytic BP. Limiting salt intake in food and modifying dialysate sodium delivery are the first stages in managing HTN in end-stage renal disease (ESRD) patients. Although it is uncertain if controlling HTN will lead to improved results, the availability of data indicates the need to manage HTN in HD patients. The key component of therapy thus involves volume status optimization, with an additional antihypertensive medicine used as suitable. The presence of HTN is a leading cause of the reduced quality of life (QoL) of HD patients. To define BP targets and monitoring methods, as well as to develop therapeutic options for more effective management of HTN in this high-risk group of HD patients, high-quality prospective studies are essential. Published data from Pakistan is insufficient when it comes to the management of uncontrolled HTN in HD patients and the factors that contribute to it.